References
- Eaton BR, Morton JA, Pickles M, White KE. A new antibody, anti-Yta, characterizing a blood-group antigen of high incidence. Br J Haematol 1956;2:333–41.
- Race RR, Sanger R. Blood groups in man. 4th ed. Oxford, England: Blackwell Scientific Publications, 1962:320–1.
- Bergvalds H, Stock A, McClure PD. A further example of anti-Yta. Vox Sang 1965;10:627–30.
- Dobbs JV, Prutting DL, Adebahr ME, Allen FH Jr, Alter AA. Clinical experience with three examples of anti-Yta. Vox Sang 1968;15:216–21.
- Allen FH Jr, Milkovich L, Corcoran PA. A pedigree showing that Yta is not in the Lutheran blood-group system. Vox Sang 1963;8:376–7.
- Giles CM, Metaxas MN. Identification of the predicted blood group antibody anti-Ytb. Nature 1964;202:1122–3.
- Giles CM, Metaxas-Bühler M, Romanski Y, Metaxas MN. Studies on the Yt blood group system. Vox Sang 1967;13: 171–80.
- Ikin EW, Giles CM, Plaut G. A second example of anti-Ytb. Vox Sang 1965;10:212–13.
- Wurzel HA, Haesler W Jr. Another example of anti-Ytb. Vox Sang 1968;14:460–1.
- Garratty G, Dzik W, Issitt PD, Lublin DM, Reid ME, Zelinski T. Terminology for blood group antigens and genes—historical origins and guidelines in the new millennium. Transfusion 2000;40:477–89.
- Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004:332–7.
- Schenkel-Brunner H. Human blood groups. Chemical and biochemical basis of antigen specificity. 2nd ed. New York, NY: Springer, 2000:553–5.
- Daniels G. Human blood groups. 2nd ed. Malden, MA: Blackwell Science, 2002:369–73.
- Daniels DL, Fletcher A, Garratty G, Henry S, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004;87:304–16.
- Garratty G, Dzik W, Issitt PD, Lublin DM, Reid ME, Zelinski T. Terminology for blood group antigens and genes—historical origins and guidelines in the new millennium. Transfusion 2000;40:477–89.
- Shows TB, McAlpine PJ, Boucheix C, et al. Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet 1987; 46:11–28.
- Levene C, Cohen T, Manny N, Bar-Shany S, Moulds JJ. Yt (Cartwright) blood groups among Israeli Jews. Transfusion 1985;25:180.
- Levene C, Asher O, Shinar E, Yahalom V. Rare blood donors: a personal approach. Immunohematology 2006;22:64–8.
- Levene C, Bar-Shany S, Manny N, Moulds JJ, Cohen T. The Yt blood groups in Israeli Jews, Arabs, and Druse. Transfusion 1987;27:471–4.
- Wurzel HA, Haesler WE. The Yt blood groups in American Negroes. Vox Sang 1968;15:304–5.
- Lewis M, Kaita H, Phillips S, et al. The Yt blood group system (ISBT No. 011). Genetic studies. Vox Sang 1987;53:52–6.
- Rao N, Whitsett CF, Oxendine SM, Telen MJ. Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a–b–) phenotype. Blood 1993; 81:815–19.
- Issitt PD. Applied blood group serology. 3rd ed. Miami, FL: Montgomery Scientific Publications, 1995:387–8.
- Coghlan G, Kaita H, Belcher E, Phillips S, Lewis M. Evidence for genetic linkage between the KEL and YT blood group loci. Vox Sang 1989;57:88–9.
- Zelinski T, White L, Coghlan G, Phillips S. Assignment of the YT blood group locus to chromosome 7q. Genomics 1991; 11:165–7.
- Zelinski T, Kaita H, Lewis M, et al. The Colton blood group locus: a linkage analysis. Transfusion 1988;28:435–8.
- Zelinski T, Kaita H, Gilson T, Coghlan G, Phillipps S, Lewis M. Linkage between the Colton blood group locus and ASSP11 on chromosome 7. Genomics 1990;6:623–5.
- Zelinski T, Coghlan G, Myal Y, et al. Genetic linkage between the Kell blood group system and prolactin-inducible protein loci: provisional assignment of KEL to chromosome 7. Ann Hum Genet 1991;55:137–40.
- Getman DK, Eubanks JH, Camp S, Evans GA, Taylor P. The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am J Hum Genet 1992;51:170–7.
- Massoulie J, Toutant JP. Vertebrate cholinesterase: structure and types of interaction. In: Whittaker VP, ed. Handbook of experimental pharmacology, vol 86. Berlin, Germany: Springer, 1988:167–224.
- Taylor P. The cholinesterases. J Biol Chem 1991; 266:4025–8.
- Lawson AA, Barr RD. Acetylcholinesterase in red blood cells. Am J Hematol 1987;26:101–12.
- Spring FA, Gardner B, Anstee DJ. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood 1992;80:2136–41.
- Bartels CF, Zelinski T, Lockridge O. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am J Hum Genet 1993;52: 928–36.
- Branch DR, Meunsch HA, Sy Siok Hian AL, Petz LD. Disulfide bonds are a requirement for Kell and Cartwright (Yta ) blood group antigen integrity. Brit J Haematol 1983;54:573–8.
- Avent ND. Human erythrocyte antigen expression: its molecular bases. Br J Biomed Sci 1997;54:16–37.
- Anstee DJ. Blood group-active surface molecules of the human red blood cell. Vox Sang 1990;58:1–20.
- Vengelen-Tyler V, Morel PA. Serologic and IgG subclass characterization of Cartwright (Yt) and Gerbich (Ge) antibodies. Transfusion 1983;23:114–16.
- Levene C, Harel N. 2-Aminoethylisothiouronium-treated red cells and the Cartwright (Yta ) antigen. Transfusion 1984; 24: 541.
- Telen MJ, Rosse WF, Parker CJ, Moulds MK, Moulds JJ. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins. Blood 1990;75:1404–7.
- Roberts WL, Myher JJ, Kuksis A, Low MG, Rosenberry TL. Lipid analysis of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase. Palmitoylation of inositol results in resistance to phosphatidylinositol-specific phospholipase C. J Biol Chem 1988;263:18766–75.
- Drew SI, Carter BM, Terasaki PI, et al. Cell surface antigens detected on mature and leukemic granulocyte populations by cytotoxicity testing. Tissue Antigens 1978;12:75–86.
- Pierce SR. A review of erythrocyte antigens shared with leukocytes. In: Bell CA, ed. A seminar on antigens on blood cells and body fluids. Washington, DC: AABB Press, 1980: 50–96.
- Dunstan RA. Status of major red cell group antigens on neutrophils, lymphocytes and monocytes. Br J Haematol 1986;62;301–9.
- Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.
- Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004; 44:1273–81.
- Bettigole R, Harris JP, Tegoli J, Issitt PD. Rapid in vivo destruction of Yt(a+) red cells in a patient with anti-Yt. Vox Sang 1968;14:143–6.
- Göbel U, Drescher KH, Pöttgen W, Lehr HJ. A second example of anti-Yta with rapid in vivo destruction of Yt(a+) red cells. Vox Sang 1974;27:171–5.
- Ballas SK, Sherwood WC. Rapid in vivo destruction of Yt(a+) erythrocytes in a recipient with anti-Yta. Transfusion 1977;17:65–6.
- Davey RJ, Simpkins SS. 51 Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta. Transfusion 1981;21:702–5.
- Silvergleid AJ, Wells RF, Hafleigh EB, Korn G, Kellner JJ, Grumet FC. Compatibility test using 51 chromium-labeled red blood cells in crossmatch positive patients. Transfusion 1978;18:8–14.
- AuBuchon JP, Brightman A, Anderson HJ, Kim B. An example of anti-Yta demonstrating a change in its clinical significance. Vox Sang 1988;55:171–5.
- Mazzi G, Raineri A, Santarossa L, De Roia D, Orazi BM. Presence of anti-Yta antibody in a Yt(a+) patient. Vox Sang 1994 66:130–2.
- Mohandas K, Spivack M, Delehanty CL. Management of patients with anti-Cartwright (Yta ). Transfusion 1985;25: 382–4.
- Levy GJ, Selset D, McQuiston D, Nance SJ, Garratty G, Smith LE, Goldfinger D. Clinical significance of anti-Ytb. Report of a case using a 51 chromium red cell survival study. Transfusion 1988;28:265–7.
- Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term 51 Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8.